The trajectory of Viagra, originally marketed by copyright, presents a fascinating case study for backers considering the drug arena . While its groundbreaking success and impact of countless in earnings , the intellectual property end has opened the floodgates for generic medications, greatly eroding profit opportunities. This transition raises qu